SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-281385
Filing Date
2018-09-24
Accepted
2018-09-24 17:27:09
Documents
2
Period of Report
2018-09-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d626868d8k.htm 8-K 16112
2 EX-5.1 d626868dex51.htm EX-5.1 18437
  Complete submission text file 0001193125-18-281385.txt   35639
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 181084231
SIC: 2836 Biological Products, (No Diagnostic Substances)